Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00457886 · ClinicalTrials.gov registry record
Measurement of Hormone Levels in Patients Receiving 17-HPC for Preterm Delivery
A clinical trial of Preterm Delivery, sponsored by Georgetown University.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT00457886: Completed study of Preterm Delivery, sponsored by Georgetown University.
NCT00457886 is a study of Preterm Delivery that has completed, run by Georgetown University. The registered enrollment target is 20 participants, below the 591-participant average among 4 other Preterm Delivery trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00457886, a study of Preterm Delivery, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to measure hormones in the blood known to affect the timing of delivery after a single injection of 17-P in order to help understand its mechanism of action in preventing preterm delivery.
Conditions Studied
Study Locations (1)
District of Columbia
- Georgetown University Medical Center - Washington D.C.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2005-07 |
| Est. Completion | 2007-06 |
What the finished NCT00457886 record still lists
NCT00457886 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 591-participant average among 4 other Preterm Delivery trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Preterm Delivery appearing as the primary indexed condition, and to 0 interventions.
NCT00457886 reports a single indexed study location in District of Columbia.
Frequently Asked Questions
What is clinical trial NCT00457886 about?
NCT00457886 is a clinical study titled "Measurement of Hormone Levels in Patients Receiving 17-HPC for Preterm Delivery". The purpose of this study is to measure hormones in the blood known to affect the timing of delivery after a single injection of 17-P in order to help understand its mechanism of action in preventing preterm delivery.
What is the current status of trial NCT00457886?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2005-07. Estimated completion is 2007-06.
What conditions does trial NCT00457886 study?
This clinical trial studies the following conditions: Preterm Delivery.
Who is sponsoring clinical trial NCT00457886?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00457886 being conducted?
This trial has 1 study location across District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Delivery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial
RECRUITING · Phase 3
-
A Randomized Trial Comparing the Impact of One Versus Two Courses of Antenatal Steroids (ACS) on Neonatal Outcome
COMPLETED · Phase 4
-
Randomized Trial to Evaluate the Effectiveness of Nurse Case Management
COMPLETED · NA
-
User Testing and Feedback for a Mobile Health Program for Postpartum Women: A Pilot Study
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia